Senzime AB (publ)
STO:SEZI
Senzime AB (publ)
STO:SEZI
Price:
6.58 SEK
4.44%
Market Closed
Updated:
May 29, 2024
Section:
Relative Value
The Relative Value of one
SEZI
stock under the Base Case scenario is
10.45
SEK.
Compared to the current market price of 6.58 SEK,
Senzime AB (publ)
is
Undervalued by 37%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SEZI
Relative Value
Base Case
10.45
SEK
Undervaluation 37%
Valuation Multiples
Multiples Across Competitors
SEZI Competitors Multiples
Senzime AB (publ) Competitors
Senzime AB (publ) Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Senzime AB (publ)
STO:SEZI
|
661.7m SEK | 16.3 | -5 | -4.8 | -4.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
177.4B USD | 4.4 | 31.5 | 18.6 | 27.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
142.2B USD | 19.4 | 71.6 | 58.8 | 73.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
129.2B USD | 6.2 | 38.5 | 24.9 | 30.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.5B USD | 7.5 | 62.6 | 31.4 | 46.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.5B USD | 3.3 | 29.3 | 13.4 | 18.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
65.9B USD | 3.3 | 50 | 17.5 | 35.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
60.2B EUR | 2.8 | 32.7 | 18.5 | 27.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52.4B USD | 8.5 | 37.1 | 26.9 | 29.1 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.5B USD | 13.3 | 78.9 | 59 | 76.8 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
365.6B CNY | 10.2 | 30 | 27.6 | 27.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
